Literature DB >> 8621487

Differential function of Wilms' tumor gene WT1 splice isoforms in transcriptional regulation.

S M Hewitt1, G C Fraizer, Y J Wu, F J Rauscher, G F Saunders.   

Abstract

The Wilms' tumor gene, WT1, encodes a zinc finger transcription factor that can repress transcription of a number of genes. WT1 mRNA undergoes alternative splicing at two locations, yielding four different mRNA species and protein products. One alternative splice alters the zinc finger region of WT1, resulting in the addition of three amino acids, Lys-Thr-Ser (KTS), between zinc fingers 3 and 4, altering the binding of WT1 to DNA. Here, we show that the WT1 protein with and without the KTS tripeptide can repress transcription from the human full-length WT1 promoter. Repression of transcription by WT1 has been shown to require two WT1 binding sites. We examined WT1 repression of the human minimal WT1 promoter, which contains two potential WT1 binding motifs. WT1 lacking the KTS tripeptide (WT1-KTS) was unable to repress transcription from a minimal WT1 promoter of 104 base pairs, whereas WT1 containing the KTS tripeptide (WT1+KTS) repressed transcription from the minimal promoter. The ability of WT1+KTS to repress transcription where WT1-KTS could not provided a functional assay to define differential WT1 binding motifs based on the presence or the absence of the KTS tripeptides. We present data defining the differential consensus DNA binding motifs for WT1-KTS and WT1+KTS. We demonstrate that WT1 zinc finger 1 plays a role in the differential DNA binding specificity of WT1-KTS and WT1+KTS.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8621487     DOI: 10.1074/jbc.271.15.8588

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  13 in total

Review 1.  Adoptive transfer of unselected or leukemia-reactive T-cells in the treatment of relapse following allogeneic hematopoietic cell transplantation.

Authors:  Richard J O'Reilly; Tao Dao; Guenther Koehne; David Scheinberg; Ekaterina Doubrovina
Journal:  Semin Immunol       Date:  2010-05-26       Impact factor: 11.130

2.  Polymorphisms in the Wilms Tumor Gene Are Associated With Interindividual Variations in Rubella Virus-Specific Cellular Immunity After Measles-Mumps-Rubella II Vaccination.

Authors:  Emily A Voigt; Iana H Haralambieva; Beth L Larrabee; Richard B Kennedy; Inna G Ovsyannikova; Daniel J Schaid; Gregory A Poland
Journal:  J Infect Dis       Date:  2018-01-30       Impact factor: 5.226

Review 3.  WT1 and glomerular diseases.

Authors:  Patrick Niaudet; Marie-Claire Gubler
Journal:  Pediatr Nephrol       Date:  2006-08-23       Impact factor: 3.714

4.  Dominant negative murine serum response factor: alternative splicing within the activation domain inhibits transactivation of serum response factor binding targets.

Authors:  N S Belaguli; W Zhou; T H Trinh; M W Majesky; R J Schwartz
Journal:  Mol Cell Biol       Date:  1999-07       Impact factor: 4.272

Review 5.  Male sex determination: insights into molecular mechanisms.

Authors:  Kathryn McClelland; Josephine Bowles; Peter Koopman
Journal:  Asian J Androl       Date:  2011-12-19       Impact factor: 3.285

6.  Alternative splice variants of the USH3A gene Clarin 1 (CLRN1).

Authors:  Hanna Västinsalo; Reetta Jalkanen; Astra Dinculescu; Juha Isosomppi; Scott Geller; John G Flannery; William W Hauswirth; Eeva-Marja Sankila
Journal:  Eur J Hum Genet       Date:  2010-08-18       Impact factor: 4.246

7.  Sustained AWT1 expression by Dupuytren's disease myofibroblasts promotes a proinflammatory milieu.

Authors:  Johnny Luo; Trisiah Tugade; Emmy Sun; Ana Maria Pena Diaz; David B O'Gorman
Journal:  J Cell Commun Signal       Date:  2022-04-12       Impact factor: 5.782

8.  The lck promoter-driven expression of the Wilms tumor gene WT1 blocks intrathymic differentiation of T-lineage cells.

Authors:  Hanfen Li; Yoshihiro Oka; Akihiro Tsuboi; Tamotsu Yamagami; Toru Miyazaki; Sei-ichi Yusa; Kotomi Kawasaki; Yukiko Kishimoto; Momotaro Asada; Hiroko Nakajima; Keisuke Kanato; Sumiyuki Nishida; Tomoki Masuda; Masaki Murakami; Naoki Hosen; Manabu Kawakami; Hiroyasu Ogawa; Fritz Melchers; Ichiro Kawase; Yusuke Oji; Haruo Sugiyama
Journal:  Int J Hematol       Date:  2003-06       Impact factor: 2.490

Review 9.  Mechanisms of transcriptional regulation by WT1 (Wilms' tumour 1).

Authors:  Eneda Toska; Stefan G E Roberts
Journal:  Biochem J       Date:  2014-07-01       Impact factor: 3.857

10.  Down-regulation of Wilms' tumor 1 expression in glioblastoma cells increases radiosensitivity independently of p53.

Authors:  Aaron J Clark; Dana C Chan; Mike Y Chen; Helen Fillmore; Wagner G Dos Santos; Timothy E Van Meter; Martin R Graf; William C Broaddus
Journal:  J Neurooncol       Date:  2007-01-06       Impact factor: 4.506

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.